BKYI Quote, Financials, Valuation and Earnings

Iveda Solutions has a net margin of -34.45% compared to BIO-key International's net margin of -23.14%. BIO-key International's return on equity of -662.7% beat Iveda Solutions's return on equity of -60.54%.

BIO-key International has a consensus price target of --, signalling upside risk potential of 197.03%. On the other hand Iveda Solutions has an analysts' consensus of -- which suggests that it could grow by 157.24%. Given that BIO-key International has higher upside potential than Iveda Solutions, analysts believe BIO-key International is more attractive than Iveda Solutions.

BIO-key International has a beta of 0.152, which suggesting that the stock is 84.842% less volatile than S&P 500. In comparison Iveda Solutions has a beta of 1.112, suggesting its more volatile than the S&P 500 by 11.23%.

BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Iveda Solutions offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International pays -- of its earnings as a dividend. Iveda Solutions pays out -- of its earnings as a dividend.

BIO-key International quarterly revenues are $2.1M, which are smaller than Iveda Solutions quarterly revenues of $2.4M. BIO-key International's net income of -$739K is lower than Iveda Solutions's net income of -$555K. Notably, BIO-key International's price-to-earnings ratio is -- while Iveda Solutions's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.20x versus 1.19x for Iveda Solutions. Usually stocks with elevated PS ratios are considered overvalued.

NAPCO Security Technologies has a net margin of -34.45% compared to BIO-key International's net margin of 25.42%. BIO-key International's return on equity of -662.7% beat NAPCO Security Technologies's return on equity of 30.38%.

BIO-key International has a consensus price target of --, signalling upside risk potential of 197.03%. On the other hand NAPCO Security Technologies has an analysts' consensus of $47.00 which suggests that it could grow by 30.23%. Given that BIO-key International has higher upside potential than NAPCO Security Technologies, analysts believe BIO-key International is more attractive than NAPCO Security Technologies.

BIO-key International has a beta of 0.152, which suggesting that the stock is 84.842% less volatile than S&P 500. In comparison NAPCO Security Technologies has a beta of 1.622, suggesting its more volatile than the S&P 500 by 62.177%.

BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NAPCO Security Technologies offers a yield of 1.25% to investors and pays a quarterly dividend of $0.13 per share. BIO-key International pays -- of its earnings as a dividend. NAPCO Security Technologies pays out 26.61% of its earnings as a dividend. NAPCO Security Technologies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

BIO-key International quarterly revenues are $2.1M, which are smaller than NAPCO Security Technologies quarterly revenues of $44M. BIO-key International's net income of -$739K is lower than NAPCO Security Technologies's net income of $11.2M. Notably, BIO-key International's price-to-earnings ratio is -- while NAPCO Security Technologies's PE ratio is 26.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.20x versus 7.01x for NAPCO Security Technologies. Usually stocks with elevated PS ratios are considered overvalued.

Universal Security Instruments has a net margin of -34.45% compared to BIO-key International's net margin of 8.01%. BIO-key International's return on equity of -662.7% beat Universal Security Instruments's return on equity of -4.73%.

BIO-key International has a consensus price target of --, signalling upside risk potential of 197.03%. On the other hand Universal Security Instruments has an analysts' consensus of -- which suggests that it could fall by --. Given that BIO-key International has higher upside potential than Universal Security Instruments, analysts believe BIO-key International is more attractive than Universal Security Instruments.

BIO-key International has a beta of 0.152, which suggesting that the stock is 84.842% less volatile than S&P 500. In comparison Universal Security Instruments has a beta of 0.735, suggesting its less volatile than the S&P 500 by 26.466%.

BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Universal Security Instruments offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International pays -- of its earnings as a dividend. Universal Security Instruments pays out -- of its earnings as a dividend.

BIO-key International quarterly revenues are $2.1M, which are smaller than Universal Security Instruments quarterly revenues of $7.2M. BIO-key International's net income of -$739K is lower than Universal Security Instruments's net income of $577K. Notably, BIO-key International's price-to-earnings ratio is -- while Universal Security Instruments's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.20x versus 0.25x for Universal Security Instruments. Usually stocks with elevated PS ratios are considered overvalued.

VerifyMe has a net margin of -34.45% compared to BIO-key International's net margin of -44.6%. BIO-key International's return on equity of -662.7% beat VerifyMe's return on equity of -27.97%.

BIO-key International has a consensus price target of --, signalling upside risk potential of 197.03%. On the other hand VerifyMe has an analysts' consensus of -- which suggests that it could grow by 251.56%. Given that VerifyMe has higher upside potential than BIO-key International, analysts believe VerifyMe is more attractive than BIO-key International.

BIO-key International has a beta of 0.152, which suggesting that the stock is 84.842% less volatile than S&P 500. In comparison VerifyMe has a beta of 0.628, suggesting its less volatile than the S&P 500 by 37.25%.

BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VerifyMe offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International pays -- of its earnings as a dividend. VerifyMe pays out -- of its earnings as a dividend.

BIO-key International quarterly revenues are $2.1M, which are smaller than VerifyMe quarterly revenues of $5.4M. BIO-key International's net income of -$739K is higher than VerifyMe's net income of -$2.4M. Notably, BIO-key International's price-to-earnings ratio is -- while VerifyMe's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.20x versus 0.26x for VerifyMe. Usually stocks with elevated PS ratios are considered overvalued.